Just days after showing off the Galaxy S26 , Samsung is finally rolling out the ability for users to unlock their home with a tap of their phone or by simply approaching their door. The new feature, called Digital Home Key, will live inside Samsung Wallet and is powered by the Aliro smart home standard. Samsung first teased its Digital Home Key feature in 2024 and said the feature would be availab...
Just days after showing off the Galaxy S26 , Samsung is finally rolling out the ability for users to unlock their home with a tap of their phone or by simply approaching their door. The new feature, called Digital Home Key, will live inside Samsung Wallet and is powered by the Aliro smart home standard. Samsung first teased its Digital Home Key feature in 2024 and said the feature would be available in 2025. That didn't pan out, as the CSA's Aliro standard - which will let users unlock smart locks with any phone - only arrived in February of this year. The new standard uses near-field communication (NFC) for its tap-to-unlock technology. It … Read the full story at The Verge.
In this article NVO LLY NVO Follow your favorite stocks CREATE FREE ACCOUNT Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capacities to make the newly launched Wegovy pill, the Danish drugmaker said Monday. The news comes about two months after Novo launched its blockbuster weight loss drug Wegovy in pill form in the U.S. market, i...
In this article NVO LLY NVO Follow your favorite stocks CREATE FREE ACCOUNT Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capacities to make the newly launched Wegovy pill, the Danish drugmaker said Monday. The news comes about two months after Novo launched its blockbuster weight loss drug Wegovy in pill form in the U.S. market, in what has been described as one of the strongest launches ever. "With the investment in the Athlone facility, Novo Nordisk is expanding its production capacities for oral products, which will strengthen our ability to meet both current and future demand, outside the US," said Kasper Bødker Mejlvang, Novo's executive vice president of chemistry, manufacturing and controls and product supply. It follows Novo Nordisk losing market share to Eli Lilly , and investors doubting that its pipeline holds enough promise to win it back. The stock has tumbled as a result, and currently trades at roughly a quarter of what it did at its peak in mid-2024. "The investment is a sign of increasing focus and bet on the oral space from Novo Nordisk – an area where Novo has an edge," Jyske Bank analyst Henrik Hallengreen Laustsen told CNBC Monday. Ensuring Wegovy supply Novo enjoyed a first-mover advantage in the anti-obesity market and launched its GLP-1 drug semaglutide, sold as Ozempic and Wegovy, years before Lilly's rival medicine. It did, however, misjudge the demand for its weight loss jabs. With semaglutide in short supply, compounding pharmacies were allowed to flourish through a loophole in U.S. regulations, which allows the legal making of patented drugs during a shortage. Supply issues have since been resolved as Novo ramped up manufacturing capacity. Even so, compunders continue to sell cheaper copycat versions of the drug, and it is still weighing on Novo's sales . The company is involved in multiple legal battles over intellectual property. Novo has repeatedly said it has enough ...
3D_generator Barclays cut its rating on Blue Owl Capital Inc. ( OWL ) to Equalweight from Overweight and upgraded StepStone Group ( STEP ) to Overweight from Equalweight as the firm assessed AI fears' impact on private credit in general and business development companies' (BDC), in particular. In its coverage of alternative asset managers, the bank lowered BDC-related earnings on lower flow assump...
3D_generator Barclays cut its rating on Blue Owl Capital Inc. ( OWL ) to Equalweight from Overweight and upgraded StepStone Group ( STEP ) to Overweight from Equalweight as the firm assessed AI fears' impact on private credit in general and business development companies' (BDC), in particular. In its coverage of alternative asset managers, the bank lowered BDC-related earnings on lower flow assumptions and realizations. Blue Owl ( OWL ) stock fell 1.1% while StepStone ( STEP ) gained 2.1% in Monday morning trading. In discussing the Blue Owl ( OWL ) downgrade, analyst Benjamin Budish wrote, "Our call here is not predicated on any assumption of worsening credit performance — though we acknowledge that this risk exists — but on numbers." In comparison with other stocks in Barclays' coverage, Blue Owl ( OWL ) depends more on non-traded BDCs than any other name. ICIC and OTIC, together, comprise ~20% of FY2025 fee-related revenue. "Going into F26, these funds are on track to be in outflow," he added. For Blue Owl's largest fund, OCIC, inflows slowed from ~$600M/month through November to ~$340M/month in December, then to $208M in February. Meanwhile, quarterly redemptions increased to just over 5% of net asset value in Q4, or over $1B in outflows. Furthermore, those figures don't reflect any impact from the software/AI-related fears that emerged in February, "which we think should cause inflows to weaken and redemption requests to potentially be worse," Budish wrote. For StepStone ( STEP ), the analyst sees an attractive entry point after recent stock underperformance. "In the wealth channel, where we view STEP as having meaningfully punched above its weight class, we note the company is far less exposed to non-traded BDCs and credit more broadly than public peers, with wealth product CREDX representing only 7% of total wealth NAV and a LSD% (low single digit percentage) of total FPAUM," Budish said. Moreover, Barclays isn't seeing a meaningful slowdown in flows to the c...
Sketch featured parodies of JK Rowling, Bill Cosby and Mel Gibson saying controversial remarks were due to TS Saturday Night Live is under fire for a sketch that poked fun at the Bafta N-word incident, with a leading Tourette syndrome (TS) charity calling it “horrific.” Filmed in the style of an informational public service announcement, the segment featured SNL cast members as public figures expl...
Sketch featured parodies of JK Rowling, Bill Cosby and Mel Gibson saying controversial remarks were due to TS Saturday Night Live is under fire for a sketch that poked fun at the Bafta N-word incident, with a leading Tourette syndrome (TS) charity calling it “horrific.” Filmed in the style of an informational public service announcement, the segment featured SNL cast members as public figures explaining that their controversial comments were because of TS. The sketch was cut for time on Saturday night’s NBC show but was uploaded to YouTube shortly after. Continue reading...
Officials continue to investigate Sunday shooting in Texas amid fears of further attacks following US airstrikes on Iran Austin bar shooting leaves three dead, including suspect, and 14 wounded Officials in Texas are continuing to investigate a weekend mass shooting at an Austin bar by a man wearing a “Property of Allah” hoodie as an act of potential terrorism, as fears rise over the possibility o...
Officials continue to investigate Sunday shooting in Texas amid fears of further attacks following US airstrikes on Iran Austin bar shooting leaves three dead, including suspect, and 14 wounded Officials in Texas are continuing to investigate a weekend mass shooting at an Austin bar by a man wearing a “Property of Allah” hoodie as an act of potential terrorism, as fears rise over the possibility of further attacks following US airstrikes on Iran. Police shot and killed Ndiaga Diagne, 53, a Senegalese national and naturalized US citizen, early on Sunday after he reportedly opened fire at the downtown bar popular with university students. Two people were killed, and another 14 wounded, some of them seriously. Continue reading...
Mobile World Congress 2026 opened its doors today in Barcelona, Spain, but some of the biggest announcements from the mobile-focused show were already made over the weekend. To make sure you don't miss the best new smartphones, laptops, concepts, and accessories, we're rounding up all the most newsworthy gadgets that have debuted so far at MWC 2026. And if you want to stay on top of all the news, ...
Mobile World Congress 2026 opened its doors today in Barcelona, Spain, but some of the biggest announcements from the mobile-focused show were already made over the weekend. To make sure you don't miss the best new smartphones, laptops, concepts, and accessories, we're rounding up all the most newsworthy gadgets that have debuted so far at MWC 2026. And if you want to stay on top of all the news, you can follow our full coverage of the show right here. Honor Robot Phone After first announcing it last October , Honor shared more details about its Robot Phone at MWC 2026 while also demoing a functional unit. The company confirmed plans to l … Read the full story at The Verge.
ARMMY PICCA/iStock via Getty Images The following segment was excerpted from the Nomura Value Fund Q4 2025 Commentary. Within the Fund For 4Q2025, Nomura Value Fund institutional Class shares modestly trailed its benchmark, the Russell 1000® Value Index. At the portfolio level, stock selection detracted from relative returns while sector allocation contributed. At the sector level, investments in ...
ARMMY PICCA/iStock via Getty Images The following segment was excerpted from the Nomura Value Fund Q4 2025 Commentary. Within the Fund For 4Q2025, Nomura Value Fund institutional Class shares modestly trailed its benchmark, the Russell 1000® Value Index. At the portfolio level, stock selection detracted from relative returns while sector allocation contributed. At the sector level, investments in the information technology ( IT ), consumer discretionary, and industrials sectors detracted the most from relative performance; investments in communication services, financials, and healthcare were notable contributors. In terms of sector allocation, the Fund's underweight in consumer staples was the primary contributor and its overweight in real estate was the primary detractor. Teledyne Technologies Inc. ( TDY ), a maker of infrared cameras, drones, and other high-tech aerospace and industrial equipment, was a primary detractor. Teledyne's shares moved lower after the company reported results for 3Q2025 and remained under pressure for much of the quarter. Quarterly revenue and cash flow hit record highs and were ahead of consensus estimates. Earnings per share (EPS) was also better than expected but was down sequentially because of restructuring costs and increased research and development (R&D) spending. On the company's earnings call, Teledyne's management issued conservative guidance for the full year and called out the government shutdown as a potential near-term risk, which appeared to spook investors. In our view, Teledyne is exposed to attractive end markets and is positioning itself to improve future growth and profitability. Jacobs Solutions Inc. ( J ), a provider of engineering, construction, and design services, was another notable detractor. Shares fell after Jacobs reported mixed results for 3Q2025 and provided guidance for 2026 that was mostly ahead of expectations. The sell-off was driven by concerns among investors about potential threats to Jacobs' busi...
Ken Griffin, CEO of Citadel LLC speaks on Squawk on the Street at the World Economic Forum in Davos, Switzerland on Jan. 21, 2026. Oscar Molina | CNBC Billionaire investor Ken Griffin' s various hedge funds at Citadel generated positive returns in February, navigating a volatile month for markets as macro uncertainty and disruption from artificial intelligence whipsawed asset prices. The firm's fl...
Ken Griffin, CEO of Citadel LLC speaks on Squawk on the Street at the World Economic Forum in Davos, Switzerland on Jan. 21, 2026. Oscar Molina | CNBC Billionaire investor Ken Griffin' s various hedge funds at Citadel generated positive returns in February, navigating a volatile month for markets as macro uncertainty and disruption from artificial intelligence whipsawed asset prices. The firm's flagship multistrategy Wellington fund rose 1.9% in February, bringing its year-to-date gain to 2.9%, according to a person familiar with the matter who asked not to be named because the information is private. Performance was broad-based across the fund, with all five of Citadel's core strategies — commodities, equities, fixed income, credit and quantitative — finishing the month in positive territory, the person said The tactical trading fund advanced 1.5% in February, lifting its year-to-date return to 3.5%, the person said. The equities fund gained 1.0% for the month and is now up 2.2% in 2026. Meanwhile, the global fixed-income fund climbed 1.6% in February, bringing its year-to-date increase to 2.9%, according to the person. The S&P 500 fell 0.9% in February amid fresh selling pressure in AI-linked and software shares. Fears that automation could erode established business models and trigger mounting layoffs have dampened investor sentiment, raising concerns about potential spillover effects on the broader economy. The market fell under massive pressure again after the U.S. and Israel's attack on Iran caused oil prices to surge. The firm declined to comment. Citadel oversaw $66 billion in assets under management as of Feb. 1.
Catherine Delahaye/DigitalVision via Getty Images Xponential Fitness, Inc. ( XPOF ) released a very concerning Q4 report, sending the stock plummeting by -47% post-earnings. The fitness brand franchisor’s performance seems to be deteriorating underneath, making the future outlook very volatile after Q4 still showed relatively stable revenues. The report questions Xponential’s ability to grow in li...
Catherine Delahaye/DigitalVision via Getty Images Xponential Fitness, Inc. ( XPOF ) released a very concerning Q4 report, sending the stock plummeting by -47% post-earnings. The fitness brand franchisor’s performance seems to be deteriorating underneath, making the future outlook very volatile after Q4 still showed relatively stable revenues. The report questions Xponential’s ability to grow in line with its previous Investor Day targets and makes upside potential very volatile despite a cheap stock price. I initiated the stock at a Buy rating in my previous July 2025 article on the stock, titled “ Xponential Fitness: Focus Shifts To Growth Potential, As SEC Investigation Ends.” The thesis hasn’t turned out well after the worrying Q4 report. The stock has since lost 57% of its value; meanwhile, the S&P 500 has returned 10%. My Rating History on XPOF (Seeking Alpha) Xponential’s Q4 Report Highlights Concerns of Franchisee Health Xponential's Q4 report was very concerning. The quarter’s financials, the forward guidance for 2026, and underlying operational metrics show a very mixed view of the company’s underlying operational performance. I believe that Q4 surface-level financials themselves were slow, but fair. Revenues came in at $83.0 million for the quarter, down by -0.3% year-on-year; the topline continued quite a similar trend from previous quarters . The most important, high-margin franchise revenue stream continued to expand with 13.7% growth to $51.5 million, reflecting Xponential’s overall franchise expansion, but also increased non-recurring franchise territory revenues related to delinquent franchise licenses’ resolving . The number of global studios stands at 3097 at the end of 2025, up by 6.9% year-on-year. An increased number of studios also enabled great 18.4% growth in merchandise revenues to $7.2 million. At the same time, other revenue streams performed much worse. Xponential generated much less equipment revenue related to new openings, its take rat...